🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators propose a nonrandomized, Phase I study to assess the safe...
Status
Withdrawn
Location
Hammersmith Hospital
Start Date
2011-04
Trial ID
NCT01336478
Clinical trial phase I and II, single-center, historical control, to evalua...
Status
Completed
Location
Hospital General Universitario Gregorio Marañón
Start Date
2017-11-02
Trial ID
NCT03669172
Treatments Being Tested
The main goal of this study is to evaluate the anti-relapse prophylactic ac...
Status
Completed
Location
Hospital Universitario de Cruces
Start Date
2016-05
Trial ID
NCT02763475
Treatments Being Tested
RATIONALE: Giving chemotherapy, natural killer cells, aldesleukin, and tota...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2006-02
Trial ID
NCT00354172
This study will find the maximum tolerated dose (MTD) of CYNK-001 which con...
Status
Unknown
Location
Colorado Blood Cancer Institute
Start Date
2020-05-12
Trial ID
NCT04309084
Treatments Being Tested
This example study is an open-label, multi-center, adaptive Phase 1/2 trial...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07744256
Treatments Being Tested
A phase I dose escalation study of veltuzumab and milatuzumab in relapsed a...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2009-09
Trial ID
NCT00989586
The trial investigates the efficacy of adoptive immunotherapy with haploide...
Status
Terminated
Location
Klinikum Bayreuth
Start Date
2015-09
Trial ID
NCT02229266
Treatments Being Tested
A Phase 1 dose-finding study of Universal Chimeric Antigen Receptor T-cells...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2017-06-28
Trial ID
NCT03203369
Treatments Being Tested
This study is a Phase 1 / 2 trial to determine the safety and efficacy of C...
Status
Terminated
Location
UC Irvine
Start Date
2020-09-02
Trial ID
NCT04365101
Treatments Being Tested